公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

154 记录

产品持有公司班级有效性
DG Gel DC Scan Plus80134860304GRIFOLS BRASIL LTDAIII11/12/2033
DG Gel Newborn80134860154GRIFOLS BRASIL LTDAIV28/03/2036
DG Gel Rh Pheno80134860143GRIFOLS BRASIL LTDAIV21/09/2035
DG Gel Rh Pheno+Kell80134860139GRIFOLS BRASIL LTDAIV13/09/2035
DG READER80134860165GRIFOLS BRASIL LTDAII现有
DG Reader Net80134860267GRIFOLS BRASIL LTDAII现有
DG SPIN80134869008GRIFOLS BRASIL LTDAI现有
DG THERM80134869007GRIFOLS BRASIL LTDAII现有
DG-PAPAIN80134860114GRIFOLS BRASIL LTDAI现有
Data-Cyte Extend 0.8%80134860284GRIFOLS BRASIL LTDAIII08/08/2032
Data-Cyte Plus 3%80134860300GRIFOLS BRASIL LTDAIII23/10/2033
Data-Cyte Plus P 0.8%80134860279GRIFOLS BRASIL LTDAIII30/08/2031
Data-Cyte® Plus 0.8%80134860250GRIFOLS BRASIL LTDAIII17/07/2027
Diego(a)-Cyte 0.8%80134860280GRIFOLS BRASIL LTDAIII06/09/2031
Diego(a)-Cyte 3%80134860316GRIFOLS BRASIL LTDAIII30/06/2035
Discriminatory Probe Reagent (Procleix ArboPlex Assay)80134860313GRIFOLS BRASIL LTDAIV22/04/2035
Discriminatory Probe Reagent kit (Procleix UltrioPlex E)80134860320GRIFOLS BRASIL LTDAIV15/09/2035
ERYTRA80134860157GRIFOLS BRASIL LTDAII现有
Enlisst-II80134860287GRIFOLS BRASIL LTDAI现有
Erytra Eflexis80134860252GRIFOLS BRASIL LTDAII现有
Essential II Control80134860214GRIFOLS BRASIL LTDAIV03/11/2035
Extended IV Control80134860213GRIFOLS BRASIL LTDAIV03/11/2035
FAMÍLIA DE INCUBADORAS PROCLEIX RPI80134860221GRIFOLS BRASIL LTDAI现有
FRACTIOMATIC PLUS 280134860158GRIFOLS BRASIL LTDAI现有
FRACTIOMATIC PLUS 380134869016GRIFOLS BRASIL LTDAI现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家